Analyst firms · Raymond James · CME

Raymond James CME price target and rating history

CME Group Inc. (CME) · Finance

Raymond James rates CME Group Inc. (CME) Outperform with a $287 price target, as of its latest action on Mar 10, 2025. It has published 5 rating actions on CME since October 2021, including 1 upgrade and 1 downgrade. Across 5 firms with a CME price target in the last 12 months, the median target is $305.

Current rating
Outperform
Price target
$287
Median target, all firms
$305
Actions on CME
5

Raymond James price target on CME

$287$259$23020222023202420252026
Raymond James price target on CME, each point a stated target, October 2021 to March 2025.

Every Raymond James rating on CME

How other firms rate CME

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoOverweight$301Oct 2, 2026
Deutsche BankHold$270Aug 19, 2026
Keefe, Bruyette & WoodsOutperform$305Jun 18, 2026
Rothschild & Co RedburnBuy$323Jun 11, 2026
Erste GroupHoldJun 5, 2026
Argus ResearchHoldMar 4, 2026
TD CowenBuy$305Jan 14, 2026

Questions about Raymond James and CME

What is Raymond James's price target for CME?
Raymond James's latest stated price target for CME Group Inc. (CME) is $287, from its action on Mar 10, 2025.
What is Raymond James's rating on CME?
Raymond James rates CME Outperform, a bullish rating, as of Mar 10, 2025.
When did Raymond James last change its view on CME?
On Mar 10, 2025, Raymond James upgrades to Outperform from Mkt Perform, price target $287.
How does Raymond James's CME target compare with other analysts?
Across 5 firms with a CME price target in the last 12 months, the median target is $305.

More CME rating histories

All Raymond James ratingsCME news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.